APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 281 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $995,359 | -0.6% | 10,926 | -28.1% | 0.00% | 0.0% |
| Q1 2023 | $1,001,866 | +12.7% | 15,189 | -11.6% | 0.00% | 0.0% |
| Q4 2022 | $888,947 | +54.9% | 17,191 | +104.7% | 0.00% | +100.0% |
| Q3 2022 | $574,000 | +52.7% | 8,399 | +1.1% | 0.00% | 0.0% |
| Q2 2022 | $376,000 | -72.1% | 8,307 | -79.7% | 0.00% | -66.7% |
| Q3 2021 | $1,350,000 | +375.4% | 40,966 | +812.8% | 0.00% | – |
| Q2 2021 | $284,000 | +26.2% | 4,488 | +13.9% | 0.00% | – |
| Q4 2020 | $225,000 | -53.0% | 3,941 | -75.2% | 0.00% | -100.0% |
| Q3 2020 | $479,000 | -45.5% | 15,869 | -41.0% | 0.00% | 0.0% |
| Q2 2020 | $879,000 | -4.1% | 26,913 | -21.3% | 0.00% | -50.0% |
| Q1 2020 | $917,000 | +45.3% | 34,211 | +65.9% | 0.00% | +100.0% |
| Q4 2019 | $631,000 | – | 20,620 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |